Michael earned his Bachelor’s degree from Ohio Wesleyan University, and in 1989 received his Ph.D. in Organic Chemistry from Case Western Reserve University under the guidance of Prof. Anthony J. Pearson. He joined Hercules Inc. in 1989, where as a member of a multi-disciplinary team in the Aerospace division, he investigated the use of organic materials for unique optical applications.
In 1992 he joined Rhone-Poulenc Rorer / Aventis Pharma as a Research Scientist and in 1999 he became the US Head of Chemical Process Research.
Michael joined Wyeth Research Chemical Development in Pearl River in 2001 where he was the Assistant Vice President of the Synthesis Research & Development group overseeing the Process Chemistry, Chemical Engineering Technologies and High Throughput Process Screening groups.
Michael joined Pfizer in 2010 following the Wyeth acquisition as head of the Pharmaceutical Sciences Small Molecule Technology & Innovation (T&I) Group where he established and led a team of senior leaders with wide-ranging technical backgrounds who in a matrixed environment identified promising nascent technologies, collaboratively developed operationally relevant platforms, and supported implementation of the most promising technologies.
Michael has recently set up a consulting LLC called NextGenTech Pharma Consulting.